Updates are available Correction dated 2023-04-26

Article History

Received: 16 October 2020

Accepted: 29 January 2021

First Online: 9 March 2021

Change Date: 26 April 2023

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s12028-023-01728-y

Author Contributions

: The study concept and design were given by NJ, PB, AC and PLL. Data acquisition was performed by NJ, EB, SP, AM, JML, AC, PB, MC and PS. Data analysis was performed by NJ, EB, MC and PS. NJ prepared the first draft of the manuscript. Interpretation of the data was done by NJ, EB, SP, AM, CR, JML, AC, PB, MC, PLL and PS. All authors provided critical feedback of the manuscript and approved the final version.

: None.

: Dr. Joram has nothing to disclose. Dr. Beqiri has nothing to disclose. Dr. Pezzato has nothing to disclose. Dr. Moscatelli has nothing to disclose. Dr. Robba has nothing to disclose. Dr. Liet has nothing to disclose. Dr. Chenouard has nothing to disclose. Dr. Bourgoin has nothing to disclose. Dr. Czosnyka reports personal fees from Cambridge Enterprise Ltd, UK, during the conduct of the study. Dr. Léger has nothing to disclose. Dr. Smielewski reports and receives part of licensing fees for the brain monitoring software ICM+ (Cambridge Enterprise Ltd, Cambridge, UK) used in this project.

: The study was approved by the local Ethics Committee (Date 07/25/2018). Information of the parents was provided before inclusion. The only criterion for non-inclusion was a parental refusal.

: ClinicalTrials.gov (NCT04282525, February 21, 2020)ExternalRef removed